$25.24
-0.30 (-1.17%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
+298.2% upside
Low Target
$77.00
Average Target
$100.50
High Target
$121.27
Current Price
$25.24
Current
$25.24
$25.24
Target
$100.50
$100.50
$77.00
$100.50 avg
$121.27
Scenario Analysis
Bear Case
$77.00
205.1%
Low target
Base Case
$100.50
+298.2%
Avg target
Bull Case
$121.27
+380.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$31.74
-20.5% from high
52-Week Low
$11.68
+116.1% from low
50-Day SMA
$22.13
+14.1% vs SMA
200-Day SMA
$15.14
+66.7% vs SMA
RSI (14)
36.6
Neutral
Target vs 52W High
$100.50
+216.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.6% |
| AMGN | Hold | 43 | 47% | $190.87 | -51.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +140.9% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.2% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -13.6% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -61.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |